Fabriccio Letellier, MD
Pulmonary Disease · Palmetto Bay, FLNPI 1285620088
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,053 of the $5,639 with a category attached, or 71.9%. 22 manufacturers reported payments, led by Johnson & Johnson at 25.5% of the total. Reporting peaked in 2022 at $2,430 and has fallen 95.3% since, to $114 in 2025.
Across 164 payments — averaging $34.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AstraZeneca$1K
- Bayer$667
- GSK$504
- Actelion Pharmaceuticals US, Inc.$488
- Boehringer Ingelheim$295
- plus $1K from 16 others
What the payments were for
- Consulting fees$2004%
- Travel & lodging$1,15320%
- Food & beverage$4,05372%
- Education$2334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $1,435 |
| AstraZeneca | 33 | $1,077 |
| Bayer | 16 | $667 |
| GSK | 16 | $504 |
| Actelion Pharmaceuticals US, Inc. | 17 | $488 |
| Boehringer Ingelheim | 14 | $295 |
| Grifols USA, LLC | 15 | $246 |
| Sanofi | 3 | $163 |
| Insmed, Inc. | 4 | $118 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Genentech USA, Inc. | 4 | $96 |
| Mylan Specialty L.p. | 5 | $80 |
| Shire North American Group Inc | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Chiesi USA, Inc. | 2 | $42 |
| Merck | 2 | $39 |
| Mallinckrodt Hospital Products Inc. | 2 | $38 |
| Electromed, Inc. | 2 | $32 |
| Mallinckrodt Enterprises LLC | 1 | $27 |
| Amgen | 1 | $24 |
| Pfizer | 1 | $18 |
| Advanced Respiratory, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,639 in reported general payments places this provider in the 60th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Palmetto Bay
- Franck RahaghiWeston$1.2M
- Michael OttEglin Afb$909K
- Ali JiwaniOrlando$859K
- Anas HadehWeston$800K
- Jennifer FultonJacksonville$665K
- Ricardo Restrepo-JaramilloTampa$555K
- Mark RumbakTampa$528K
- Jose Soto SotoJacksonville$504K
- Javier Perez FernandezMiami$496K
- Domenick ReinaTampa$469K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.